Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? (Q44127294)

30 November 2017

Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? (English)

1 reference

30 November 2017

0 references

2

Djillali Annane

1 reference

30 November 2017

Marco Confalonieri

1

1 reference

30 November 2017

Caterina Antonaglia

3

1 reference

30 November 2017

Mario Santagiuliana

4

1 reference

30 November 2017

Ediva M Borriello

5

1 reference

30 November 2017

G Umberto Meduri

6

1 reference

30 November 2017

1 April 2013

1 reference

Current infectious disease reports

30 November 2017

1 reference

30 November 2017

15

1 reference

30 November 2017

2

1 reference

30 November 2017

158-166

1 reference

Trends in infectious disease mortality in the United States during the 20th century

30 November 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Pneumonia: still the old man's friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Factors of importance for the long term prognosis after hospital treated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Outcomes and costs among seniors requiring hospitalization for community-acquired pneumonia in Alberta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Medium-term survival after hospitalization with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Decrease in long-term survival for hospitalized patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Predictors of short-term rehospitalization following discharge of patients hospitalized with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Determinants of short and long term functional recovery after hospitalization for community-acquired pneumonia in the elderly: role of inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Long-term cognitive impairment and functional disability among survivors of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans Affairs Healthcare System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Acute lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Prevalence and significance of coagulation abnormalities in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Glucocorticoids regulate arrestin gene expression and redirect the signaling profile of G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Molecular mechanisms of glucocorticoid action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Adrenal insufficiency in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Corticosteroid treatment in severe community-acquired pneumonia: duration of treatment affects control of systemic inflammation and clinical improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Effects of glucocorticoids in ventilated piglets with severe pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Prolonged glucocorticoid treatment and secondary prevention in acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Management of Community-acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-013-0322-8

The balance between expression of intranuclear NF-kappaB and glucocorticoid receptor in polymorphonuclear leukocytes in SIRS patients

21 January 2018

1 reference

12 December 2020

Compartmentalized cytokine production within the human lung in unilateral pneumonia

1 reference

12 December 2020

Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance

1 reference

12 December 2020

Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses.

1 reference

12 December 2020

Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study

1 reference

12 December 2020

Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial

1 reference

12 December 2020

The multiple organ dysfunction syndrome and late-phase mortality in sepsis

1 reference

12 December 2020

Glucocorticoid treatment in community-acquired pneumonia

1 reference

12 December 2020

Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to

1 reference

12 December 2020

Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection

1 reference

12 December 2020

Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization

1 reference

12 December 2020

Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study

1 reference

12 December 2020

Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status

1 reference

12 December 2020

Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone

1 reference

12 December 2020

Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment

1 reference

12 December 2020

Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man

1 reference

12 December 2020

The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin

1 reference

12 December 2020

Dose- and time-dependent activation of rat alveolar macrophages by glucocorticoids

1 reference

12 December 2020

Glucocorticoid treatment in community-acquired pneumonia without severe sepsis: no evidence of efficacy

1 reference

12 December 2020

10.1007/S11908-013-0322-8

Identifiers

DOI

1 reference

30 November 2017

1 reference